See more : Kinnate Biopharma Inc. (KNTE) Income Statement Analysis – Financial Results
Complete financial analysis of MT Genex Corporation (9820.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MT Genex Corporation, a leading company in the Specialty Business Services industry within the Industrials sector.
- Correlate Infrastructure Partners Inc. (CIPI) Income Statement Analysis – Financial Results
- Orex Minerals Inc. (REX.V) Income Statement Analysis – Financial Results
- Johnson Electric Holdings Limited (JELCF) Income Statement Analysis – Financial Results
- Unilever PLC (UNI2.DE) Income Statement Analysis – Financial Results
- Digital Transformation Opportunities Corp. (DTOC) Income Statement Analysis – Financial Results
MT Genex Corporation (9820.T)
About MT Genex Corporation
MT Genex Corporation, together with its subsidiaries, operates as a contractor for construction and renovation of houses and office buildings in Japan. It operates through four segments: Renewal, Parking, Facilities Maintenance Management, and Insurance Agency. The company undertakes interior and external construction and renewal work for buildings and residences, as well as provides design and construction supervision for real estate properties. It is also involved in the operation, management, and lease of parking lots; and operation and management of real estate properties. In addition, the company plans and proposes risk management plans, such as various non-life insurance solutions. Further, it engages in the provision of real estate development; hotel management; and maintenance works for electrical equipment systems. The company was founded in 1945 and is headquartered in Tokyo, Japan. MT Genex Corporation operates as a subsidiary of Mori Trust Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 3.79B | 3.26B | 2.97B | 3.01B | 3.26B |
| Cost of Revenue | 2.83B | 2.41B | 2.17B | 2.25B | 2.37B |
| Gross Profit | 961.50M | 849.46M | 805.24M | 762.97M | 895.00M |
| Gross Profit Ratio | 25.36% | 26.03% | 27.11% | 25.35% | 27.42% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 49.00M | 75.00M | 66.00M | 58.00M | 43.00M |
| Selling & Marketing | 427.00M | 367.00M | 368.00M | 370.00M | 328.00M |
| SG&A | 475.00M | 442.00M | 434.00M | 428.00M | 371.00M |
| Other Expenses | 47.00M | 2.48M | 3.01M | 1.12M | 0.00 |
| Operating Expenses | 523.15M | 484.46M | 476.11M | 453.72M | 377.00M |
| Cost & Expenses | 3.35B | 2.90B | 2.64B | 2.70B | 2.75B |
| Interest Income | 9.44M | 9.77M | 10.73M | 10.32M | 9.07M |
| Interest Expense | 561.00K | 698.00K | 1.06M | 684.00K | 0.00 |
| Depreciation & Amortization | 50.44M | 44.52M | 44.60M | 27.16M | 8.00M |
| EBITDA | 502.80M | 427.79M | 387.80M | 356.20M | 526.00M |
| EBITDA Ratio | 13.26% | 12.96% | 13.08% | 11.58% | 16.12% |
| Operating Income | 438.35M | 365.00M | 329.13M | 309.26M | 518.00M |
| Operating Income Ratio | 11.56% | 11.19% | 11.08% | 10.28% | 15.87% |
| Total Other Income/Expenses | 13.45M | 17.57M | 13.01M | 19.10M | 9.00M |
| Income Before Tax | 451.80M | 382.57M | 342.14M | 328.35M | 527.00M |
| Income Before Tax Ratio | 11.92% | 11.72% | 11.52% | 10.91% | 16.15% |
| Income Tax Expense | 174.23M | 140.91M | 129.52M | 100.88M | 181.00M |
| Net Income | 277.57M | 241.66M | 212.62M | 227.47M | 346.00M |
| Net Income Ratio | 7.32% | 7.41% | 7.16% | 7.56% | 10.60% |
| EPS | 257.43 | 224.49 | 197.52 | 211.30 | 321.56 |
| EPS Diluted | 257.43 | 224.49 | 197.52 | 211.30 | 321.56 |
| Weighted Avg Shares Out | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
| Weighted Avg Shares Out (Dil) | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
Source: https://incomestatements.info
Category: Stock Reports